Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers.
Mohamed A GoudaHelen J HuangSarina A Piha-PaulS Greg CallDaniel D KarpSiqing FuAung NaingVivek SubbiahShubham PantDerek J DustinApostolia-Maria TsimberidouDavid S HongJordi Rodon AhnertFunda Meric-BernstamFilip JankuPublished in: JCO precision oncology (2022)
Detection of ctDNA and early dynamic changes in its quantity can predict the clinical outcomes of systemic therapies in patients with advanced solid tumors.